136 related articles for article (PubMed ID: 21178064)
21. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.
Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A
Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670
[TBL] [Abstract][Full Text] [Related]
22. Influence of N-butylscopolamine on SUV in FDG PET of the bowel.
Sanghera B; Emmott J; Wellsted D; Chambers J; Wong WL
Ann Nucl Med; 2009 Jul; 23(5):471-8. PubMed ID: 19444552
[TBL] [Abstract][Full Text] [Related]
23. Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET?
Tochetto SM; Rezai P; Rezvani M; Nikolaidis P; Berggruen S; Atassi B; Salem R; Yaghmai V
Radiology; 2010 Apr; 255(1):164-72. PubMed ID: 20308454
[TBL] [Abstract][Full Text] [Related]
24. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
[TBL] [Abstract][Full Text] [Related]
25. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of CT density in patients with diffusely increased FDG uptake in the thyroid gland on PET/CT images.
Han YM; Kim YC; Park EK; Choe JG
AJR Am J Roentgenol; 2010 Jul; 195(1):223-8. PubMed ID: 20566820
[TBL] [Abstract][Full Text] [Related]
27. The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients.
Ali MA; El-Abd E; Morsi M; El Safwany MM; El-Sayed MZ
Eur J Hybrid Imaging; 2023 Oct; 7(1):19. PubMed ID: 37840056
[TBL] [Abstract][Full Text] [Related]
28. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
[TBL] [Abstract][Full Text] [Related]
29. The effect of 18F-FDG-PET/CT respiratory gating on detected metabolic activity in lung lesions.
Lupi A; Zaroccolo M; Salgarello M; Malfatti V; Zanco P
Ann Nucl Med; 2009 Feb; 23(2):191-6. PubMed ID: 19225943
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
Ouyang L; Shi ZY; Lin ZG
Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
[TBL] [Abstract][Full Text] [Related]
31. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
32. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
33. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
34. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
Szyszko T; Al-Nahhas A; Canelo R; Habib N; Jiao L; Wasan H; Pagou M; Tait P
Nucl Med Commun; 2007 Jan; 28(1):15-20. PubMed ID: 17159544
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of standardized uptake value normalized by individual CT-based lean body mass in application of PET response criteria in solid tumors (PERCIST).
Narita A; Shiomi S; Katayama Y; Yamanaga T; Daisaki H; Hamada K; Watanabe Y
Radiol Phys Technol; 2016 Jul; 9(2):170-7. PubMed ID: 26873140
[TBL] [Abstract][Full Text] [Related]
37. Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study.
Yu J; Li X; Xing L; Mu D; Fu Z; Sun X; Sun X; Yang G; Zhang B; Sun X; Ling CC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1468-74. PubMed ID: 19464822
[TBL] [Abstract][Full Text] [Related]
38. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
[TBL] [Abstract][Full Text] [Related]
39. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
[TBL] [Abstract][Full Text] [Related]
40. Hepatic and splenic
Keramida G; Roldao Pereira L; Kaya G; Peters AM
Clin Physiol Funct Imaging; 2020 Mar; 40(2):99-105. PubMed ID: 31769591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
